SCHEMBL1243050

SCHEMBL1243050

Cc1cc(C)c(-c2c(C)cc(C)c(C)c2O)c(O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
BCL2 P10415 3/20 0.38
MCL1 Q07820 3/20 0.38
BCL2L1 Q07817 3/20 0.38
BCL2L2 Q92843 2/20 0.38
TRPA1 O75762 1/20 0.36
KDM4E B2RXH2 5/20 0.36
MAPT P10636 5/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
USP2 O75604 2/20 0.36
SELL P14151 1/20 0.35
SELP P16109 1/20 0.35
SELE P16581 1/20 0.35
ACHE P22303 1/20 0.35
HPGD P15428 3/20 0.33
LMNA P02545 3/20 0.33
GAA P10253 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL204468 0.84 ALDH1A1 (0.47) ALDH1A1CA1CA2TRPA1KDM4E
SCHEMBL15485452 0.84 ALDH1A1 (0.47) ALDH1A1CA1CA2TRPA1KDM4E
SCHEMBL24595228 0.82 AKR1B1 (0.38) MAPTMEN1KMT2AACHEHPGD
SCHEMBL28040473 0.81 ALDH1A1 (0.45) ALDH1A1CA1CA2TRPA1KDM4E
SCHEMBL21002133 0.80 ACHE (0.46) ALDH1A1CA1CA2BCL2MCL1
SCHEMBL5680954 0.79 CA1 (0.50) ALDH1A1CA1CA2TRPA1KDM4E
SCHEMBL12950152 0.78 SLC22A8 (0.31) BCL2MCL1
SCHEMBL28186211 0.77 ALDH1A1 (0.50) ALDH1A1CA1CA2TRPA1KDM4E
SCHEMBL992674 0.77 CA1 (0.48) ALDH1A1CA1CA2TRPA1KDM4E
Formaldehyde SCHEMBL27723108 0.77 ALDH1A1 (0.41) ALDH1A1CA1CA2TRPA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200375949-A1 BISPHENOL COMPOUNDS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2020-12-03 US claimed
US-9517986-B2 Process for preparing 2,2′-biphenols using selenium dioxide EVONIK DEGUSSA GMBH (DE) 2016-12-13 US claimed
US-20150336865-A1 PROCESS FOR PREPARING 2,2'-BIPHENOLS USING SELENIUM DIOXIDE EVONIK DEGUSSA GMBH (DE) 2015-11-26 US claimed
WO-2004069779-A1 METHOD FOR PRODUCING 2,2'-DIHYDROXYBIPHENYLS BASF AKTIENGESELLSCHAFT (DE) 2004-08-19 WO claimed
JP-10045648-A None JP disclosed
US-20200375949-A1 BISPHENOL COMPOUNDS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2020-12-03 US disclosed
WO-2019104153-A1 BISPHENOL COMPOUNDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2019-05-31 WO disclosed
EP-2949638-B1 METHOD FOR THE PREPARATION OF 2,2 -BIPHENOLS USING SELENIUM DIOXIDE EVONIK DEGUSSA GMBH (DE) 2017-11-08 EP disclosed
US-9517986-B2 Process for preparing 2,2′-biphenols using selenium dioxide EVONIK DEGUSSA GMBH (DE) 2016-12-13 US disclosed
EP-2949638-A1 METHOD FOR THE PREPARATION OF 2,2 -BIPHENOLS USING SELENIUM DIOXIDE Evonik Degussa GmbH (DE) 2015-12-02 EP disclosed
US-20150336865-A1 PROCESS FOR PREPARING 2,2'-BIPHENOLS USING SELENIUM DIOXIDE EVONIK DEGUSSA GMBH (DE) 2015-11-26 US disclosed
EP-1467958-B1 PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHENOLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHENOLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIPHENOLS INVISTA TECH SARL (CH) 2014-01-08 EP disclosed
EP-1214289-A1 MULTIDENTATE PHOSPHITE LIGANDS AND CATALYTIC COMPOSITIONS CONTAINING SAME E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-06-19 EP disclosed
EP-1214282-A2 HYDROFORMYLATION PROCESS UTILIZING MULTIDENTATE PHOSPHITE LIGANDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-06-19 EP disclosed
EP-1214290-A1 MULTIDENTATE PHOSPHITE LIGANDS AND CATALYTIC COMPOSITIONS CONTAINING THEM E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-06-19 EP disclosed
US-6380421-B1 HYDROCYANATION PROCESS E. I. DU PONT DE NEMOURS AND COMPANY 2002-04-30 US disclosed
WO-2001021567-A2 HYDROFORMYLATION PROCESS UTILIZING MULTIDENTATE PHOSPHITE LIGANDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-03-29 WO disclosed
WO-2001021579-A1 MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-03-29 WO disclosed
WO-2001021580-A1 MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-03-29 WO disclosed
JP-H1045648-A SEPARATION OF OPTICAL ISOMER OF DIHYDROXYBIPHENYL DERIVATIVE DAICEL CHEM IND LTD 1998-02-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200375949-A1 BISPHENOL COMPOUNDS RPP30, RPS10, RPS20 ALDH1A1 1053/4885CA1 4530/4885CA2 3489/4885
US-20150336865-A1 PROCESS FOR PREPARING 2,2'-BIPHENOLS USING SELENIUM DIOXIDE SELENOI, PLK1, BPGM ALDH1A1 2479/4885CA1 1654/4885CA2 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.